Table 2.
Variable | Odds ratio | 95% Cl |
---|---|---|
Previous TNF antagonist exposure (no vs yes) | 1.758 | 1.194–2.587 |
Disease duration (≥2 y vs <2 y) | 1.689 | 1.018–2.803 |
Baseline endoscopy (moderate vs severe) | 1.447 | 0.991–2.114 |
Baseline albumin | 1.067 | 1.024–1.112 |
CI, confidence interval; TNF, tumor necrosis factor; VDZ, vedolizumab.